| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |